首页> 外文期刊>Vaccine >Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX((R))
【24h】

Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX((R))

机译:佐剂ISCOMATRIX(R)协同增强了对流感抗原的局部免疫应答

获取原文
获取原文并翻译 | 示例

摘要

The peripheral (draining) lymph node. as the primary site of immune induction, determines the course of systemic responses to an injected antigen. Lymphatic duct cannulation procedures in sheep were used to investigate local immunoreactivity to human influenza virus antigen (Flu ag) admixed with the adjuvant ISCOMATRIX (R) (IMX). Compared to Flu ag or IMX alone. the co-administration of Flu ag and IMX (Flu ag + IMX) synergistically enhanced a number of immunological responses (lymphocyte and blast migration from the node. antigen-specific antibody levels and IL6 output in efferent lymph, and antigen-induced proliferation in cultured efferent lymph cells). Together, these results demonstrate that IMX is an immune modulator, and that lymphatic duct cannulation procedures may be used to evaluate antigen/adjuvant combinations for vaccine development.
机译:外周(引流)淋巴结。作为免疫诱导的主要部位,它决定了对注射抗原的全身反应过程。使用绵羊的淋巴管插管程序来研究与佐剂ISCOMATRIX(R)(IMX)混合的人流感病毒抗原(Flu ag)的局部免疫反应性。与单独的Flu ag或IMX相比。 Flu ag和IMX(Flu ag + IMX)的共同给药可协同增强多种免疫反应(淋巴结中的淋巴细胞和胚盘迁移,传出淋巴中的抗原特异性抗体水平和IL6输出以及培养物中抗原诱导的增殖)传出的淋巴细胞)。总之,这些结果表明IMX是一种免疫调节剂,并且淋巴管插管程序可用于评估抗原/佐剂组合以开发疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号